Clinical Trials
6 trialsNCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT06933966 2025-04-18
ATTENUATION
Centre Leon Berard
Phase 2 Not yet recruiting
NCT06515964 2024-07-23
China Early Esophageal Cancer Cohort
Changhai Hospital
Recruiting
NCT06272214 2024-07-16
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT03220009 2018-10-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00767234 2016-07-11
Permission to Collect Blood Over Time for Research
Stanford University
Terminated